Abstract
Much of the history of acute renal failure and its managment is derived from wartime experience. The phenomenon of acute post-traumatic renal failure was recognized by Bywaters and Beall [1] in military and civilian casualties during World War II; unfortunately, hemodialysis was not yet available at that time. Conventional hemodialysis was first used in chnical practice in 1944, when Kolff [2] successfully dialyzed a 45-year-old woman with drug-induced oliguric acute renal failure and uremic encephalopathy. By the early 1950s, Swan and Merrill [3] were able to achieve a survival rate of 54% in 85 acute renal failure patients, using the Kolff-Brigham coil hemodialyzer [4]. These techniques were later applied successfully during the Korean War.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bywaters E, Beall O (1941) Crush injuries with impairment of renal function. Br J Med 1:427–436
Kolff W (1946) The artificial kidney. Medical dissertation, University of Groningen
Swan R, Merrill J (1953) Clinical course of acute renal failure. Medicine (Baldmore) 32:215
Murphy W, Swan R, Walter C, Weiler J, Merrill J (1952) Use of an artificial kidney. III. Current procedures in clinical hemodialysis. J Lab Clin Med 40:436–444
Wilmore D (1991) CataboHc illness: strategies for enhancing recovery. N Engl J Med 325(10):695–702
Ziegler T, Young L, Manson J, Wilmore D (1988) Metabolic effects of recombinant human growth hormone in patients receiving parenteral nutrition. Ann Surg 208:6–16
Bidani A, Churchill P (1983) Aminophylline ameliorates glycerol-induced acute renal failure in rats. Can J Physiol Pharmacol 61(6):567–571
Parker S, Carlon G, Isaacs M, Howland W, Kahn R (1981) Dopamine administration in oliguric and non-oliguric renal failure. Crit Care Med 9:630–632
Rudy D, Voelker J, Greene P, Esparza F, Brater D (1991) Loop diuretics for chronic renal failure: a condnuous infusion is more efficacious than bolus therapy. Ann Intern Med 115(5):360–366
Inoue M, Okajima K, Itoh K et al. (1987) Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients. Kidney Int 32(2): 198–203
Anderson C, Shahvari M, Zimmerman J (1979) The treatment of pulmonary edema in the absence of renal function — a role for sorbitol and furosemide. JAMA 241:1008–1110
Choi M, Fernandez P, Patnaik A et al. (1993) Brief report: trimethoprim-induced hyperkalemia in a patient with AIDS. N Engl J Med 328(10):703–706
Hohnloser S, Verrier R, Lown B (1987) Influence of beta 2-adrenoceptor stimulation and blockade on cardiac electrophysiologic properties and serum potassium concentration in the anesthetized dog. Am Heart J 113(5): 1066–1070
Flinn R, Merrill J, Wlezant W (1961) Treatment of the oliguric patient with a new sodium exchange resin and sorbitol. N Engl J Med 264:111–114
Gerstman B, Kirkman R, Piatt R (1992) Intestinal necrosis associated with postoperative orally administered sodium polystyrene sulfonate in sorbitol. Am J Kidney Dis 20:159–161
Brown T, Ahern D, Nolph K (1973) Potassium removal with peritoneal dialysis. Kidney Int 4:67–69
Hou S, McElroy P, Nootens J, Beach M (1989) Safety and efficacy of low-potassium dialysate. Am J Kidney Dis 13:137–143
Remuzzi G, Pusineri F (1988) Coagulation defects in uremia. Kidney Int Suppl 24:S13-S17
Janson P, Jubeliere S, Weinstein M, Deykin D (1980) Treatment of the bleeding tendency of uremia with cryoprecipitate. N Engl J Med 303(23):1318–1322
Mannucci P, Remuzzi G, Pusineri F et al. (1983) Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 308(1):8–12
Locke S, Merrill J, Tyler H (1961) Neurologic complications of acute uremia. Arch Intern Med 108:75–83
Mitch W, May R, Maroni B (1989) Mechanisms for abnormal protein metabolism in uremia. J Am Coll Nutr 8(4):305–309
Mitch W, May R, Maroni B, Druml W (1989) Protein and amino acid metabolism in uremia: influence of metabolic acidosis. Kidney Int Suppl 27:S205-S207
Molitoris B, Froment D, Mackenzie T, Huffer W, Alfrey A (1989) Citrate: a major factor in the toxicity of orally administered aluminum compounds. Kidney Int 36(6):949–953
Androgue H, Rashad M, Gorin A, Yacoub J, Madias N (1989) Assessing acid-base status in circulatory failure: differences between arterial and central venous blood. N Engl J Med 320:1312–1315
Kveim M, Nesbakken R (1975) Utilization of exogenous acetate during hemodialysis. Trans Am Soc Artif Intern Organs 21:138–143
Conger J (1975) A controlled evaluation of prophylactic dialysis in post-traumatic acute renal failure. J Trauma 15:1056–1063
Gillum D, Dixon B, Yanover M et al. (1986) The role of intensive dialysis in acute renal failure. Clin Nephrol 25:249–255
Sargent J, Gotch F (1989) Principals and biophysics of dialysis. In: Maher J (ed) Replacement of renal function by dialysis. Kluwer, Dordrecht, p 87
Babb A, Farrell P, Uvelli D, Scribner B (1972) Hemodialyzer evaluation by examination of solute molecular spectra. Trans Am Soc Artif Intern Organs 18:98–105
Henderson L (1989) Biophysics of ultrafiltration and hemofiltration. In: Maher J (ed) Replacement of renal function by dialysis. Kluwer, Dordrecht, p 300
Nolph K, Nothum R, Maher J (1974) Ultrafiltration: a mechanism for removal of intermediate molecular weight substances in coil dialyzers. Kidney Int 6:55–60
Baldamus C (1983) Clinical value and technical feasibility of long-term hemofiltration. Trans Am Soc Artif Intern Organs 6:192–195
Davison A, Roberts T, Mascie-Taylor B, Lewins A (1982) Haemofiltration for profound dialysis-induced hypotension: removal of sodium and water without blood-pressure change. Br Med J 285:87–89
Geronemus R, Schneider N (1984) Continuous arteriovenous hemodialysis: a new modahty for treatment of acute renal failure. Trans Am Soc Artif Intern Organs 30:610–612
Bellomo R, Ernest D, Love J, Parkin G, Boyce N (1990) Continuous arteriovenous haemodiafiltration: an optimal therapy for acute renal failure in the intensive care setting. Aust N Z J Med 20:237–242
Bellomo R, Parkin G, Love J, Boyce N (1992) Management of acute renal failure in the critically ill with continuous venovenous hemodiafiltration. Ren Fail 4:183–186
Jorstad S (1988) Generation and removal of anaphylatoxins during hemofiltration with 5 different membranes. Blood Purif 6:325–335
Bellomo R, Tipping P, Boyce N (1993) Continuous venovenous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 21: 522–526
Flaherty J, Garcia-Houchins S, Chudy R, Arnow P (1993) An outbreak of gram-negative bacteriemia traced to contaminated O-rings in reprocessed dialyzers. Ann Intern Med 119:1072–1078
Gordon S, Tipple M, Bland L, Jarvis W (1988) Pyrogenic reactions associated with the reuse of disposable hollow-fiber hemodialyzers. JAMA 260:2077–2081
Conger J (1983) The role of blood flow autoregulation in pathophysiology of acute renal failure. Circ Shock 11:235–244
Adams P, Adams P, Bell P, Navar L (1980) Impaired renal blood flow autoregulation in ischemic acute renal failure. Kidney Int 18:68–76
Schulman G (1993) A review of the concept of biocompatibility. Kidney Int Suppl 41:S209-S212
Himmelfarb J, Zaoui P, Hakim R (1992) Modulation of granulocyte LAM-1 and MAC-1 during dialysis — a prospective randomized controlled trial. Kidney Int 41:388–395
Himmelfarb J, Lazarus J, Hakim R (1991) Reactive oxygen species production to monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis 17: 271–276
Cheung A, Baranowski R, Wayman A (1987) The role of thromboxane in cuprophan- induced pulmonary hypertension. Kidney Int 31:1072–1079
Shaldon S, Lonnemann G, Koch K (1989) Cytokine relevance in biocompatibihty. Contrib Nephrol 79:227–236
Schindler R, Lonnemann G, Shaldon S, Koch K, Dinarello C (1990) Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. Kidney Int 37:85–93
Canivet E, Lavaud S, Wong T, Guenounou M, Willemin J, Potron G (1994) Cuprophane but not synthetic membrane induces increases in serum tumor necrosis factor-alpha levels during hemodialysis. Am J Kidney Dis 23:41–46
Schulman G. Fogo A, Gung A, Badr K, Hakim R (1991) Complement activation retards resolution of acute ischemic renal failure in the rat. Kidney Int 40:1069–1074
Hakim R, Wingard R, Parker R (1994) Dialysis membranes in the treatment of patients with acute renal failure. N Engl J Med 331:1338–1342
Wilkenson R, Barber S, Robson V (1977) Cramps, thirst, and hypertension in hemodialysis patients. Clin Nephrol 7:101–105
Port F, Johnson W, Klass D (1973) Prevention of dialysis disequilibrium syndrome by use of high sodium concentration in the dialysate. Kidney Int 3:327–333
VanStone J, Bauer J, Carey J (1980) The effect of dialysate sodium concentration on body fluid distribution during hemodialysis. Trans Am Soc Artif Intern Organs 26:383–386
Raja R, Kramer M, Barber K, Chin S (1983) Sequendal changes in dialysate sodium during dialysis. Trans Am Soc Ardf Intern Organs 29:649–651
Ward R, Wathen R, Williams T, Harding G (1987) Hemodialysate composidon and intradialytic metabolic, acid-base, and potassium changes. Kidney Int 32:129–135
Sherman R, Hwang E, Bernhole A, Eisinger R (1986) Variabihty in potassium removal by hemodialysis. Am J Nephrol 6:284–288
Henrich W (1986) Hemodynamic instability during hemodialysis. Kidney Int 30:605–612
Wolff J, Pendersen T, Rossen M, Cleeman-Rasmussen K (1986) Effects of acetate and bicarbonate dialysis on cardiac performance, transmural myocardial perfusion and acid- base balance. Int J Artif Organs 9:105–110
Vinay P, Prud’homme M, Vinet B et al. (1987) Acetate metabolism and bicarbonate generation during hemodialysis: 10 years of observadon. Kidney Int 31:1194–1204
Ebben J, Hirsh D, Luchmann D, Collins A, Kehaviah P (1987) Microbiologic contamination of liquid bicarbonate concentrate for hemodialysis. Trans Am Soc Artif Intern Organs 33:269–273
Wolfson M, Jones M, Kopple J (1982) Amino acid losses during hemodialysis with infusion of amino acids and glucose. Kidney Int 21:500–506
Ikizler A, Flakoll P, Hakim R (1993) Amino acid losses in hemodialysis with different dialysis membranes. J Am Soc Nephrol 4(3):127P
Raman A, Chong Y, Sreenevasan G (1976) Effects of varying dialysate calcium concentrations on the plasma calcium fractions in patients on dialysis. Nephron 16:181–187
Vliskin S, Belhassen B, Sheps D, Laniado S (1992) Clinical and electrophysiologic effects of magnesium sulfate on paroxysmal supraventricular tachycardia and comparison to adenosine triphosphate. Am J Cardiol 70:870–885
Roden D (1989) Magnesium treatment of ventricular arrhythmias. Am J Cardiol 63:43G-46G
Skobeloff E, Spivey W, McNamara R, Greenspon L (1989) Intravenous magnesium sulfate in the treatment of acute asthma in the emergency department. JAMA 262: 1210–1213
Hampers C, Blaufox M, Merrill J (1966) Anticoagulation rebound after hemodialysis. N Engl J Med 255:1063–1067
VonBrecht J, Flanagan M, Freeman R, Lim V (1986) Regional anticoagulation: hemodialysis with hypertonic trisodium citrate. Am J Kidney Dis 8:196–201
Harter H (1983) Review of findings from the Nadonal Cooperative Dialysis Study and recommendations. Kidney Int 23 Suppl 13:S107-S112
Owen W, Lew N, Liu Y, Lowrie E, Lazarus J (1993) The urea reduction rado and serum albumin concentration as predictors of mortality in padents undergoing hemodialysis. N Engl J Med 329(14): 1001–1006
Held P, Levin N, Bovberg R, Pauly M, Diamond L (1991) Mortality and duration of hemodialysis treatment. JAMA 257(5):645–650
Parker T (1992) Trends and concepts in the prescripdon and delivery of dialysis in the US. Semin Nephrol 12(3):267–275
Bartlett R, Dechert R, Mault J, Ferguson S, Kaiser A, Erlandson E (1982) Measurement of metabolism in multiple organ failure. Surgery 92:771–778
Langkamp-Henken B, Glezer J, Kuosk K (1992) Immunologic structure and function of the gastrointesdnal tract. Nutr Clin Praet 7(3): 100–108
Haglund U (1993) Systemic mediators released from the gut in critical illness. Crit Care Med 21 Suppl 2:S15-S18
Abel R, Beck C, Abbott W, Ryan J, Barnett G, Fischer J (1973) Improved survival from acute renal failure after treatment with intravenous essential 1-amino acids and glucose. N Engl J Med 288(14):695–699
Blumenkrantz M, Kopple J, Koffler A et al. (1978) Total parenteral nutrition in the management of acute renal failure. Am J CHn Nutr 31:1831–1840
Feinstein E, Blumenkrantz M, Healy M et al. (1981) Clinical and metabolic responses to parenteral nutrition in acute renal failure. Medicine (Baltimore) 60(2): 124–137
Mirtallo J, Schneider P, Mavko K, Ruberg R, Fabri P (1982) A comparison of essendal and general amino acid infusions in the nutritional support of patients with compromised renal function. JPEN J Parenter Enteral Nutr 6(2): 109–113
Schulman G, Wingard R, Hutchinson R, Lawrence P, Hakim R (1993) The effects of recombinant human growth hormone and intradialytic parenteral nutrition in malnourished hemodialysis padents. Am J Kidney Dis 21(5):527–534
Ziegler T, Lazarus J, Young L, Hakim R, Wilmore D (1991) Effects of recombinant human growth hormone in adults receiving maintenance hemodialysis. J Am Soc Nephrol 2(6): 1130–1135
Hou S, Bushinsky D, Wish J, Cohen J, Harrington J (1983) Hospital-acquired renal insufñciency: a prospective study. Am J Med 74:243–248
Shinaberger J, Brautbar N, Miller J, Gardner P (1978) Successful application of sequendal hemofiltration followed by diffusion dialysis with standard dialysis equipment. Trans Am Soc Artif Intern Organ 24:677–681
Asaba H, Bergstrom J, Fürst P et al. (1976) Sequendal ultrafiltration and diffusion as alternatives to conventional hemodialysis. Proc Clin Dial Transplant Forum 6:129–135
Vanholder R, Lameire N, Verbank J, von Ratdnghe R, Kunnen M, Rigoir S (1982) Complications of subclavian catheter hemodialysis: a 5-year prospective study in 257 consecutive patients. Int J Artif Organs 5(5):297–303
Cimochowski G, Worley E, Rutherford W, Sartain J, Blondin J, Harter H (1990) Superiority of internal jugular over the subclavian access for temporary dialysis. Nephron 54(2):154–161
Uldall P (1994) Subclavian cannulation is no longer necessary or justified in patients with end-stage renal failure. Semin Dial 7:161–164
Uldall P, DeBruyne M, Besley M, McMillan J, Simons M, Fraicoer R (1993) A new vascular access catheter for hemodialysis. Am J Kidney Dis 21(3):270–277
Moss A, McLaughhn M, Lempert K, Holley J (1988) Use of a silicone catheter with a Dacron cuff for dialysis short-term vascular access. Am J Kidney Dis 12(6):492–498
Sherman R, Faustino E, Bernhole A, Eisinger R (1984) Effect of variations in dialysate temperature on blood pressure during hemodialysis. Am J Kidney Dis 4:66–68
Jost C, Agarwal R, Khair-el-Din T, Grayburn P, Victor R, Henrich W (1993) Effects of cooler temperature dialysate on hemodynamic stability in problem hemodialysis patients. Kidney Int 44:606–612
Stott R, Cameron J, Ogg C, Bewick M (1972) Why the persistently high mortality in acute renal failure? Lancet 2:75–79
Lohr J, McFarlane M, Grantham J (1988) A clinical index to predict survival in acute renal failure patients requiring dialysis. Am J Kidney Dis 11:254–259
Cioffi W, Ashikaga T, Gamelli R (1984) Probabihty of surviving postoperative acute renal failure. Ann Surg 200:205–211
Spiegel D, Ullian M, Zerbe G, Bed T (1991) Determinants of survival and recovery in acute renal failure patients dialyzed in intensive care units. Am J Nephrol 11:44–47
Corwin H, Teplick R, Schreiber M, Fang L, Bonventre J, Coggins C (1987) Prediction of outcome in acute renal failure. Am J Nephrol 7:8–12
Tielemans C, Madhoun P, Lenaers M, Schandene L, Goldman M, Vanderweghem J (1990) Anaphylactoid reactions during hemodialysis on AN69 membranes in patients receiving ACE inhibitors. Kidney Int 38:982–984
Schulman G, Hakim R, Arias R, Silverberg M, Kaplan A, Arbeit L (1993) Bradykinin generation by dialysis membrane: possible role in anaphylactic reactions. J Am Soc Nephrol 3:1536–1539
Bennett W, Muther R, Parker R, Feig P, Morrison G, Golper T (1980) Drug therapy is renal failure: dosing guidelines for adults. Ann Intern Med 93:62–89
Bennett W, Aronoff G, Morrison G, Golper T, Pulham J, Wolfson M (1983) Drug prescribing in renal failure: dosing guidelines for adults. Am J Kidney Dis 3:155–193
Campistol JM, Skinner M (1993) ß2-Microglobuhn anyloidosis: an-overview. Sem Dial 6:117–126
Sherman RA, Hwang ER, Bernholc AS, Eisinger RP (1986) Variabihty in potassium removal by hemodialysis. Am J Nephrol 6:284–288.
Nissenson AR, Kraut JA, Shinaberger JH (1984) Dialysis-associated hypoxemia: pathogenesis and prevention. ASAIO J 7:1–12
Mailoux L, Schwartz CD, Capizzi R et al. (1967) Acute renal failure after administration of low-molecular weight dextran. N Engl J Med 277:113–118
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Chertow, G.M., Owen, W.F., Lazarus, J.M. (1995). Conventional Hemodialysis for Acute Renal Failure. In: Bellomo, R., Ronco, C. (eds) Acute Renal Failure in the Critically Ill. Update in Intensive Care and Emergency Medicine, vol 20. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79244-1_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-79244-1_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79246-5
Online ISBN: 978-3-642-79244-1
eBook Packages: Springer Book Archive